Table 1 Weighted characteristics of the study population based on NAFLD
From: The role of C-reactive protein to lymphocyte ratio in NAFLD and mortality among NAFLD patients
Characteristic2 | N | Overall N = 111,700,8551 | Non-NAFLD N = 58,533,7211 | NAFLD N = 53,167,1341 | p-value |
|---|---|---|---|---|---|
Age (years) | 4371 |  |  |  | < 0.001 |
 20–39 |  | 1403 (34%) | 873 (41%) | 530 (26%) |  |
 40–60 |  | 1493 (37%) | 672 (33%) | 821 (42%) |  |
 > 60 |  | 1475 (30%) | 689 (27%) | 786 (33%) |  |
Gender | 4371 |  |  |  | < 0.001 |
 Male |  | 2187 (49%) | 1013 (42%) | 1174 (56%) |  |
 Female |  | 2184 (51%) | 1221 (58%) | 963 (44%) |  |
Race and ethnicity | 4371 | Â | Â | Â | 0.002 |
 Mexican American |  | 547 (6.6%) | 231 (5.5%) | 316 (7.9%) |  |
 Other Hispanic |  | 427 (5.3%) | 196 (5.1%) | 231 (5.4%) |  |
 Non-Hispanic White |  | 1666 (69%) | 834 (69%) | 832 (69%) |  |
 Non-Hispanic Black |  | 1002 (10%) | 509 (10%) | 493 (11%) |  |
 Other Race |  | 729 (8.5%) | 464 (9.8%) | 265 (7.0%) |  |
PIR | 4371 | Â | Â | Â | 0.7 |
 < 1.0 |  | 616 (9.2%) | 323 (9.3%) | 293 (9.0%) |  |
 1.0–3.0 |  | 1829 (33%) | 894 (32%) | 935 (33%) |  |
 > 3.0 |  | 1926 (58%) | 1017 (59%) | 909 (58%) |  |
Educational level | 4371 |  |  |  | < 0.001 |
 < High school |  | 586 (7.6%) | 272 (6.5%) | 314 (8.7%) |  |
 = High school |  | 903 (21%) | 429 (19%) | 474 (23%) |  |
 > High school |  | 2882 (72%) | 1533 (75%) | 1349 (68%) |  |
BMI | 4371 |  |  |  | < 0.001 |
 < 18.5 |  | 56 (1.3%) | 56 (2.5%) | 0 (0%) |  |
 18.5–24.9 |  | 1130 (27%) | 1105 (50%) | 25 (0.9%) |  |
 25.0–29.9 |  | 1402 (31%) | 907 (40%) | 495 (21%) |  |
 ≥ 30.0 |  | 1783 (41%) | 166 (7.0%) | 1617 (78%) |  |
Hypertension | 4371 |  |  |  | < 0.001 |
 No |  | 2061 (52%) | 1337 (65%) | 724 (37%) |  |
 Yes |  | 2310 (48%) | 897 (35%) | 1413 (63%) |  |
Diabetes | 4371 |  |  |  | < 0.001 |
 No |  | 3565 (86%) | 2018 (94%) | 1547 (77%) |  |
 Yes |  | 806 (14%) | 216 (5.9%) | 590 (23%) |  |
Smoking status | 4371 | Â | Â | Â | 0.006 |
 Never |  | 2550 (59%) | 1378 (62%) | 1172 (57%) |  |
 Current |  | 1129 (27%) | 486 (24%) | 643 (31%) |  |
 Former |  | 692 (13%) | 370 (14%) | 322 (12%) |  |
CVD | 4371 |  |  |  | < 0.001 |
 Yes |  | 428 (7.5%) | 154 (5.0%) | 274 (10%) |  |
 No |  | 3943 (92%) | 2080 (95%) | 1863 (90%) |  |
Dyslipidemia | 4371 |  |  |  | < 0.001 |
 No |  | 1281 (30%) | 913 (42%) | 368 (17%) |  |
 Yes |  | 3090 (70%) | 1321 (58%) | 1769 (83%) |  |
ALT (U/L) | 4371 | 23 ± (15) | 19 ± (10) | 28 ± (17) | < 0.001 |
AST (U/L) | 4371 | 23 ± (10) | 22 ± (9) | 24 ± (11) | < 0.001 |
HDL-C (mg/dl) | 4371 | 56 ± (18) | 62 ± (18) | 48 ± (13) | < 0.001 |
TG (mg/dl) | 4371 | 146 ± (133) | 102 ± (52) | 194 ± (172) | < 0.001 |
TC (mg/dl) | 4371 | 194 ± (42) | 189 ± (40) | 198 ± (44) | < 0.001 |
UA (mg/dl) | 4371 | 5.35 ± (1.39) | 4.92 ± (1.24) | 5.82 ± (1.39) | < 0.001 |
Physical activity | 4371 |  |  |  | < 0.001 |
 Inactive |  | 1485 (30%) | 666 (24%) | 819 (36%) |  |
 Moderately active |  | 449 (10.0%) | 228 (10.0%) | 221 (9.9%) |  |
 Highly active |  | 2437 (60%) | 1340 (66%) | 1097 (54%) |  |
CLR(mg/cells*10–9) | 4371 | 1.79 ± (3.93) | 1.28 ± (4.03) | 2.36 ± (3.73) | < 0.001 |
CLR quartile3 | 4371 |  |  |  | < 0.001 |
 Q1 |  | 1068 (25%) | 823 (37%) | 245 (12%) |  |
 Q2 |  | 1029 (25%) | 593 (28%) | 436 (21%) |  |
 Q3 |  | 1145 (25%) | 484 (21%) | 661 (30%) |  |
 Q4 |  | 1129 (25%) | 334 (14%) | 795 (38%) |  |